Skip to main content
Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.930
+0.090 (4.89%)
At close: Apr 26, 2024, 4:00 PM
1.890
-0.040 (-2.07%)
After-hours: Apr 26, 2024, 7:58 PM EDT

Atai Life Sciences Revenue

In the year 2023, Atai Life Sciences had annual revenue of $314.00K with 34.76% growth. Revenue in the quarter ending December 31, 2023 was $18.00K, a -52.63% decrease year-over-year.

Revenue (ttm)
$314.00K
Revenue Growth
+34.76%
P/S Ratio
1,029.00
Revenue / Employee
$3,783
Employees
83
Market Cap
323.11M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.00K81.00K34.76%
Dec 31, 2022233.00K-20.14M-98.86%
Dec 31, 202120.38M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organogenesis Holdings 433.14M
Procaps Group 414.10M
Cerus 186.80M
Viemed Healthcare 183.01M
Ocugen 6.04M
Lyra Therapeutics 1.56M
Opthea 385.28K
Revenue Rankings

ATAI News

More News